Foto del docente

Fabrizio De Ponti

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: BIO/14 Pharmacology

Publications

Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F., Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, «JN. JOURNAL OF NEPHROLOGY», 2022, 35, pp. 1017 - 1027 [Scientific article]Open Access

Raschi E.; Diemberger I.; Sabatino M.; Poluzzi E.; De Ponti F.; Potena L., Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction, «EXPERT OPINION ON PHARMACOTHERAPY», 2022, 23, pp. 303 - 320 [Scientific article]

Martini, Silvia; Vitali, Francesca; Capelli, Irene; Donadei, Chiara; Raschi, Emanuel; Aiello, Valeria; Corvaglia, Luigi; De Ponti, Fabrizio; Poluzzi, Elisabetta; Galletti, Silvia, Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants, «PEDIATRIC RESEARCH», 2022, 91, pp. 1715 - 1722 [Scientific article]

Raschi E.; Fusaroli M.; La Placa M.; Ardizzoni A.; Zamagni C.; Poluzzi E.; De Ponti F., Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System, «AMERICAN JOURNAL OF CLINICAL DERMATOLOGY», 2022, 23, pp. 247 - 255 [Scientific article]

Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi, Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system, «EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY», 2021, 28, Article number: 2047487320915663 , pp. 983 - 989 [Scientific article]Open Access

Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems, «CLINICAL NUTRITION», 2021, 40, pp. 1176 - 1185 [Scientific article]

Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio, Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2021, 76, pp. 199 - 205 [Scientific article]

Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [Scientific article]

Raschi E.; Fusaroli M.; Ardizzoni A.; Poluzzi E.; De Ponti F., Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment, «BREAST CANCER RESEARCH AND TREATMENT», 2021, 186, pp. 219 - 227 [Scientific article]

Lee Y.-M.; Cao K.; Leech M.; De Ponti F., Developing medical artificial intelligence leaders: International university consortium approach, «MEDICAL EDUCATION», 2021, 55, pp. 1321 - 1322 [Scientific article]

Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707 , pp. 1 - 11 [Scientific article]Open Access

Gatti M.; De Ponti F., Drug Interactions with Contraceptives, in: Trends in Andrology and Sexual Medicine, Berlino, Springer Science and Business Media Deutschland GmbH, 2021, pp. 325 - 359 (TRENDS IN ANDROLOGY AND SEXUAL MEDICINE) [Chapter or essay]

Gatti M.; De Ponti F., Drug repurposing in the covid-19 era: Insights from case studies showing pharmaceutical peculiarities, «PHARMACEUTICS», 2021, 13, Article number: 302 , pp. 1 - 23 [Scientific article]Open Access

Donker E.; Brinkman D.; Richir M.; Papaioannidou P.; Likic R.; Sanz E.J.; Christiaens T.; Costa J.; De Ponti F.; Gatti M.; Bottiger Y.; Kramers C.; Garner S.; Pandit R.; Van Agtmael M.; Tichelaar J., European List of Essential Medicines for Medical Education: A protocol for a modified Delphi study, «BMJ OPEN», 2021, 11, Article number: e045635 , pp. 1 - 4 [Scientific article]Open Access

Bakkum M.J.; Richir M.C.; Papaioannidou P.; Likic R.; Sanz E.J.; Christiaens T.; Costa J.N.; Maciulaitis R.; Dima L.; Coleman J.; Tichelaar J.; van Agtmael M.A.; Atanasova I.; Ganeva M.; Gatchev E.; Kostadinova I.I.; Matanovic S.M.; Vitezic D.; Wozniak G.; Kmonickova E.; Urbanek K.; Damkier P.; Huupponen R.K.; Auffret M.; Bejan-Angoulvant T.; Chouchana L.; Cracowski J.-L.; Drici M.D.; Faillie J.L.; Geniaux H.; Molimard M.; Orlikowski D.; Palin K.; Pers Y.-M.; Picard N.; Simon N.; Toussirot E.; Boger R.H.; Cascorbi I.; Mueller S.C.; Regenthal R.; Schwab M.; Schwaninger M.S.; Thuermann P.A.; Wojnowski L.; Kouvelas D.; Riba P.; Kerins D.M.; Williams D.J.; Cosentino M.; De Ponti F.; Filippelli A.; Leone R.; Locatelli V.; Jansone B.; Gulbinovic R.; Mifsud J.; Braszko J.J.; Kocic I.; Breitenfeld L.; Castelo-Branco M.; Conea S.; Magyar I.; Bevc S.; Krzan M.; Bernal M.L.; Capella D.; Carcas A.; De Abajo F.J.; Lopez-Rico M.; Lucena M.I.; Pontes C.; Sanz E.J.; Bottiger Y.; Le Greves M.; de Waard-Siebinga I.; Janssen B.J.A.; Knol W.; Pandit R.; van Rosse F.; Dent G.; Ferro A.; Hitchings A.W.; Kapil V.; Linton K.D.; Loke Y.K.; Okorie M.; Plumb R.D.; Pontefract S.; Ranmuthu S.; Sampson A.P.; Thanacoody H.K.R.; Whitfield J.P.; Wilson K., EurOP2E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 77, pp. 1209 - 1218 [Scientific article]Open Access